Biovie is trading at $1.79 (-8.21%) during early August 24, 2026 trading amid broader risk-off pressure alongside a 0.60% Nasdaq loss.
- The decline follows a sharp multi-session rebound.
- No fresh company-specific announcement or earnings catalyst has been identified for August 24, 2026.
- The latest major development remains positive Phase 2 SUNRISE-PD data announced August 6.